Respiratory Rate Clinical Trial
Official title:
Spire Medical Health Tag Respiratory Rate Validation in Adults
The primary purpose of this study is to conduct a Respiratory Rate accuracy validation
comparing the Spire Medical Health Tag to a FDA cleared End Tidal Carbon Dioxide monitor
Reference Standard (GE Datex-Ohmeda).
After IRB approval, a minimum of 20 healthy volunteer test subjects, 18 or older will be
entered into this study designed to validate the accuracy of the respiratory rate feature of
the Spire Medical Health Tag (Device Under Test).
The subjects will be selected to represent a range of body types including small, average,
muscular, and large with a range of BMIs. Each subject will be connected to a FDA cleared
EtCO2 monitor (GE Datex-Ohmeda) and will be instrumented with a mouthpiece or open system
mask that allows for measurement of EtCO2 derived respiratory rate. A range of stable
respiratory rates will be elicited from each volunteer test subject with the use of a paced
breathing application on a mobile phone. Subjects will also be connected to a 3-lead ECG (GE
Datex-Ohmeda) for the purpose of monitoring heart rate and comparing to the pulse rate
measurements recorded by the Spire Medical Health Tag.
The respiratory rate and pulse rate will be measured simultaneously for the Reference and the
Device Under Test.
The purpose of this study is to collect data to validate the respiratory rate performance of
the Medical Health Tag developed by Spire Health. The Medical Health Tag respiratory rate
will be evaluated during non-motion conditions over the range a range of 5-50 breaths per
minute via Reference EtCO2. A FDA cleared, GE Healthcare S5 Multi-parameter monitoring system
with End Tidal Carbon Dioxide (EtCO2) and 3-lead ECG will be used for the Respiratory and
Pulse Rate References. There are no risks or adverse device effects to be assessed. There are
no contraindications for use in the proposed study / study population.
This study will focus on the respiratory rate, RR parameter. The Spire Medical Health Tag is
investigational and has not been cleared by the FDA. The intended purpose of the device under
test is spot-checking, non-invasive monitoring / logging of respiratory rate on humans. For
this evaluation, the device will be run in a continuous data collection mode.
The study population will include 20 healthy competent adults, ages 18 years and older. The
subject selection will be a mix of males and females with small to large physiques. The
subjects must understand the study and consent to participate by signing the Informed Consent
Form. The subjects must be healthy showing no evidence of medical problems as indicated by
satisfactorily completing the health assessment form and passing the health screening.
Eligible subjects need to meet all of the inclusion criteria and none of the exclusion
criteria for participation.
It is expected that the data collection will take approximately 4-7 days to complete. There
is no additional followup required for the investigation.
The data from the Device Under Test will be collected on an application installed on the iOS
or Android mobile device separate from the reference equipment.
Multi-parameter monitor used during the study to observe a subject's vital signs include ECG
tracing, heart rate, respiratory rate, and EtCO2 with capnograph.
- GE Healthcare S5 Compact Monitor, M-NESTPR module with ECG, and/or Multi-parameter
monitor
- Portable oxygen tank, mask and ambu bag
- GE Healthcare (Datex-Ohmeda) 3900 TruTrak+ / OxyTip+ Oxy-F-UN or Oxy-AF Sensor and
Oxy-OL3 cable (SpO2 monitoring)
- Blood pressure cuff and stethoscope
Currently the FDA defines respiration rate devices as Class II devices. The Device Under Test
in this study is considered non-significant risk device.
There are no risks or adverse device effects to be assessed. There are no contraindications
for use in the proposed study / study population.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03832205 -
Validation of Respiratory Rate and Heart Rate Measurements by Capaciflectors Placed in Four Locations on the Chest
|
||
Completed |
NCT04506684 -
Reveal LINQ Respiration Clinical Study
|
||
Completed |
NCT03685227 -
A Closer Look at Yoga Nidra: Sleep Lab Analyses
|
N/A | |
Completed |
NCT04179279 -
Comparative Analysis of a Non-contact Respiratory and Heart Rate Monitor Vs. a Conventional Clinically Validated Reference Monitor
|
||
Completed |
NCT04077593 -
On the PhonE Respiratory rAte Study (OPERA)
|
||
Completed |
NCT03750344 -
ChroniSense Polso Wrist Worn Respiration Rate Validation Study
|
N/A | |
Completed |
NCT05366049 -
The Effect of Methods Used in Oral Antipyretic Administration on the Vital Findings of the Child With Fever
|
N/A | |
Completed |
NCT03148873 -
RespiraSense Versus Capnography & Manual Counting
|
||
Recruiting |
NCT05263791 -
Evaluation the Non-Inferiority of Airmod to Capnostream™35
|
N/A | |
Completed |
NCT05246358 -
Respiratory Rate Validation Study - ChroniSense Polso
|
N/A | |
Recruiting |
NCT05812378 -
Respiratory Monitoring System Safety and Performance Study
|
||
Not yet recruiting |
NCT06292299 -
The PARS Study: Paediatric Advanced Respiratory Service Study - An Observational Diagnostic Feasibility Study
|
||
Recruiting |
NCT05022264 -
Remote Investigation and Assessment of Vital Signs
|
||
Completed |
NCT06086769 -
High Flow Oxygen Therapy Effect on Healthy Subjects
|
N/A | |
Completed |
NCT04064645 -
Bora Band Respiration Rate Study
|
N/A | |
Completed |
NCT01472133 -
Validation of Respiration Rate Algorithms
|
N/A | |
Completed |
NCT03306537 -
Sensor Validation Study - Quality Assurance
|
||
Active, not recruiting |
NCT03750318 -
Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital
|
N/A | |
Completed |
NCT03754231 -
Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital
|
N/A | |
Completed |
NCT04346498 -
Can Kangarooing Small Babies on the Back of a Mother Keep Them Warm and Stable
|
N/A |